AG
UTHR icon

Algert Global’s United Therapeutics UTHR Stock Holding History

Algert Global’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,160
Closed -$3.65M – 1420
2026
Q1 		$3.65M Sell
6,160
-970
-14% -$483K 0.06% 531
2025
Q4 		$3.47M Sell
7,130
-5,221
-42% -$2.43M 0.05% 558
2025
Q3 		$5.18M Buy
12,351
+6,731
+120% +$2.26M 0.09% 405
2025
Q2 		$1.61M Buy
+5,620
New +$1.68M 0.03% 697
2023
Q3 		– Sell
-5,933
Closed -$1.31M – 1263
2023
Q2 		$1.31M Buy
5,933
+400
+7% +$88.6K 0.06% 561
2023
Q1 		$1.24M Sell
5,533
-19,001
-77% -$4.68M 0.06% 550
2022
Q4 		$6.82M Sell
24,534
-712
-3% -$180K 0.38% 24
2022
Q3 		$5.29M Buy
25,246
+6,018
+31% +$1.35M 0.32% 37
2022
Q2 		$4.53M Sell
19,228
-3,124
-14% -$635K 0.34% 29
2022
Q1 		$4.01M Buy
22,352
+15,748
+238% +$3M 0.26% 59
2021
Q4 		$1.43M Buy
6,604
+1,760
+36% +$346K 0.18% 159
2021
Q3 		$894K Buy
+4,844
New +$954K 0.12% 286
2021
Q1 		– Sell
-2,320
Closed -$352K – 538
2020
Q4 		$352K Buy
+2,320
New +$304K 0.1% 281
2020
Q3 		– Sell
-4,850
Closed -$587K – 490
2020
Q2 		$587K Sell
4,850
-15,449
-76% -$1.74M 0.2% 162
2020
Q1 		$1.93M Buy
+20,299
New +$1.93M 0.81% 14
2014
Q1 		– Sell
-6,000
Closed -$678K – 374
2013
Q4 		$678K Buy
+6,000
New +$541K 0.18% 187

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Algert Global's UTHR Position: Q2 2026 in Review

Algert Global sold out of United Therapeutics (UTHR) in Q2 2026, closing a stake of 6,160 shares — an estimated $3.65M sold.

Algert Global first reported a position in UTHR in Q4 2013 and held it in 16 quarters. The position peaked at $6.82M in Q4 2022. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Algert Global reported no remaining United Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Algert Global sold 6,160 United Therapeutics shares in Q2 2026, an estimated $3.65M.
  • Algert Global first reported a position in United Therapeutics in Q4 2013 and held it in 16 quarters.
  • Algert Global's United Therapeutics position peaked at $6.82M in Q4 2022.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.